Aspirin Use and Risk of Glioma: a Double Track for a Single Goal?

  • Raffaella MormileEmail author
Letter to the Editor


Compliance with Ethical Standards

Conflict of Interest

The author declares no potential conflicts of interest.


  1. 1.
    Gusyatiner O, Hegi ME (2018 Aug) Glioma epigenetics: from subclassification to novel treatment options. Semin Cancer Biol 51:50–58CrossRefPubMedGoogle Scholar
  2. 2.
    Amirian ES, Ostrom QT, Armstrong GN, Lai RK, Gu X, Jacobs DI, Jalali A, Claus EB, Barnholtz-Sloan JS, Il'yasova D, Schildkraut JM, Ali-Osman F, Sadetzki S, Jenkins RB, LaChance DH, Olson SH, Bernstein JL, Merrell RT, Wrensch MR, Johansen C, Houlston RS, Scheurer ME, Shete S, Amos CI, Melin B, Bondy ML (2018 Nov 27. pii: cebp.0702.2018) Aspirin, non-steroidal anti-inflammatory drugs (NSAIDs), and glioma risk: original data from the glioma international case-control study and a meta-analysis. Cancer Epidemiol Biomark Prev.
  3. 3.
    Fujita M, Kohanbash G, Fellows-Mayle W, Hamilton RL, Komohara Y, Decker SA, Ohlfest JR, Okada H (2011 Apr 1) COX-2 blockade suppresses gliomagenesis by inhibiting myeloid-derived suppressor cells. Cancer Res 71(7):2664–2674CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Zhang S, Zhang C, Song Y, Zhang J, Xu J (2018) Prognostic role of survivin in patients with glioma. Medicine (Baltimore) 97(17):e0571CrossRefGoogle Scholar
  5. 5.
    Zhang F, Chu J, Wang F (2017) Expression and clinical significance of cyclooxygenase 2 and survivin in human gliomas. Oncol Lett 14(2):1303–1308CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Németh K, Szücs N, Czirják S, Reiniger L, Szabó B, Barna G, Karászi K, Igaz P, Zivkovic V, Korbonits M, Patócs A, Butz H (2018) Survivin as a potential therapeutic target of acetylsalicylic acid in pituitary adenomas. Oncotarget. 9(49):29180–29192CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2019

Authors and Affiliations

  1. 1.Division of Pediatrics and NeonatologyMoscati HospitalAversaItaly

Personalised recommendations